MD Anderson researchers uncover epigenetic mechanism reshaping Dicer enzyme in cancer and infertility

MD Anderson researchers discover how epigenetic changes reshape the Dicer enzyme, revealing new triggers for tumor progression and reproductive failure.

By: AXL Media

Published: Apr 29, 2026, 10:34 AM EDT

Source: Information for this report was sourced from University of Texas M. D. Anderson Cancer Center

The Biological Sentinel of Cell Division

The Dicer enzyme has long been recognized as a cornerstone of cellular health, responsible for the maturation of germ cells into viable ova and the regulation of proper cell division. Led by Swathi Arur, Ph.D., a professor of Genetics at MD Anderson, researchers have now closed a significant knowledge gap regarding the internal regulation of this enzyme. The team discovered that Dicer’s ability to perform its duties is not static but is instead dependent on its physical configuration, which can be altered by epigenetic signals that do not change the underlying DNA sequence.

Identifying the GRARR Control Mechanism

Through the study of C. elegans models, the research team isolated a specific arginine-rich DNA sequence known as GRARR that acts as a master switch for the enzyme. When this specific region is activated through a process called methylation, Dicer undergoes a structural shift that allows it to recruit essential partner proteins. This coordinated effort is necessary to generate 26G small RNAs, which are the primary drivers of egg development and meiotic programs. The identification of this sequence provides a clear target for understanding how small biochemical changes can have massive downstream effects on an organism's fertility.

The Epigenetic Link to Tumor Progression

In the context of oncology, the Dicer enzyme is frequently viewed as a tumor suppressor, with low levels of the protein correlating to poor survival rates across various cancer types. The MD Anderson study suggests that it is not just the presence of the enzyme that matters, but its specific shape and recruitment capabilities. In cancers where DICER1 dysfunction is present, the researchers believe that irregular epigenetic activity may be "tuning" the enzyme into a shape that fails to regulate cell division effectively. This structural failure promotes altered cell identity, potentially fueling the uncontrolled growth characteristic of malignant tumors.